Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PPALM: Tocovid SupraBio + Pentoxifylline for Radiation-Induced Fibrosis
NCT02230800Phase 2Completed
- Sponsor
- Royal Marsden NHS Foundation Trust
- Start
- Nov 2014
- Primary completion
- Dec 2019
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of tocovid, pentoxifylline in radiation-induced fibrosis (RIF), sponsored by Royal Marsden NHS Foundation Trust. Started Nov 2014; status: completed.
02
Drugs
tocovidpentoxifylline
03
Conditions
radiation-induced fibrosis (RIF)
Beyond the preview
Go deeper on NCT02230800.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02230800.